Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
72.25
+0.18 (0.25%)
At close: Jan 6, 2026, 4:00 PM EST
72.02
-0.23 (-0.32%)
After-hours: Jan 6, 2026, 7:50 PM EST

Avidity Biosciences Revenue

Avidity Biosciences had revenue of $12.48M in the quarter ending September 30, 2025, with 434.03% growth. This brings the company's revenue in the last twelve months to $20.87M, up 106.27% year-over-year. In the year 2024, Avidity Biosciences had annual revenue of $10.90M with 13.99% growth.

Revenue (ttm)
$20.87M
Revenue Growth
+106.27%
P/S Ratio
521.68
Revenue / Employee
$53,371
Employees
391
Market Cap
10.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.90M1.34M13.99%
Dec 31, 20239.56M336.00K3.64%
Dec 31, 20229.22M-102.00K-1.09%
Dec 31, 20219.33M2.54M37.41%
Dec 31, 20206.79M4.47M192.67%
Dec 31, 20192.32M1.94M511.87%
Dec 31, 2018379.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings